Merge Bio Therapeutics
Cambridge, US · Founded 2025 · Delaware corporation · 1 known investors
Founders & leadership
SL
Steve LiapisDirector
CH
Clinton HansenExecutive Officer, Promoter
EQ
Elias QuijanoDirector
WW
Wesley WongExecutive Officer, Director, Promoter
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$5MraisedSep 2025 · 1 investors · OtherRule 506(b)
▶$5MraisedSep 2025 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Mark LipsteinPromoter
- Steve LiapisDirector
- Clinton HansenExecutive Officer, Promoter
- Elias QuijanoDirector
- Wesley WongExecutive Officer, Director, Promoter
- Darren YangPromoter
- Offering amount
- $15M
- Amount sold
- $5M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.